e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NovaBay Pharmaceuticals, Inc. Common Stock
(NY:
NBY
)
1.340
-0.020 (-1.46%)
Streaming Delayed Price
Updated: 9:33 AM EDT, Oct 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NovaBay Pharmaceuticals, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
April 19, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
April 17, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
March 26, 2024
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
NovaBay Pharmaceuticals: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
Recap: NovaBay Pharmaceuticals Q3 Earnings
November 09, 2023
Via
Benzinga
Earnings Preview For NovaBay Pharmaceuticals
November 08, 2023
Via
Benzinga
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
March 26, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For March 26, 2024
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
March 25, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
March 14, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 06, 2024
Via
Benzinga
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
January 30, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
January 29, 2024
ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 29, 2024
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
January 26, 2024
Via
Benzinga
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
January 09, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
January 09, 2024
Via
ACCESSWIRE
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
December 06, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 30, 2023
Via
Benzinga
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
November 02, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
October 11, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
October 02, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
September 14, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 12, 2023
Via
Benzinga
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 12, 2023
Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via
Benzinga
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube